Outlook Therapeutics Other Operating Expenses (Quarterly) Analysis

Outlook Therapeutics, Inc. (OTLK)

0.5274 -0.01 (-2.33%) USD | NASDAQ | Jan 15, 14:13

View Other Operating Expenses (Quarterly) for OTLK.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Other Operating Expenses (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Other Operating Expenses (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Other Operating Expenses (Quarterly) Benchmarks

Start Trial

Ironwood Pharmaceuticals, Inc.	--
Amicus Therapeutics, Inc.	--
Neogen Corp.	--
CorMedix, Inc.	--
NovaBay Pharmaceuticals, Inc.	--